(Q41691958)

7 October 2017

IL-21 Modulates Activation of NKT Cells in Patients with Stage IV Malignant Melanoma (English)

1 reference

7 October 2017

4

Mark J Smyth

1 reference

7 October 2017

Jonathan M Coquet

1

1 reference

7 October 2017

Kresten Skak

series ordinal

2

1 reference

7 October 2017

Ian D Davis

series ordinal

3

1 reference

7 October 2017

Dale I Godfrey

series ordinal

5

1 reference

7 October 2017

18 October 2013

1 reference

Clinical & translational immunology

7 October 2017

1 reference

7 October 2017

2

1 reference

7 October 2017

10

1 reference

7 October 2017

e6

1 reference

A conserved human T cell population targets mycobacterial antigens presented by CD1b

7 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

Recognition of CD1d-restricted antigens by natural killer T cells

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

New insights into the regulation of T cells by gamma(c) family cytokines

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

IL-21 and TGF-beta are required for differentiation of human T(H)17 cells

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

IL-21 induces in vivo immune activation of NK cells and CD8(+) T cells in patients with metastatic melanoma and renal cell carcinoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

Interleukin 21: combination strategies for cancer therapy

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

CD1-restricted T cells and tumor immunity

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

IL-21-induced Bepsilon cell apoptosis mediated by natural killer T cells suppresses IgE responses.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

The IL-21 receptor augments Th2 effector function and alternative macrophage activation

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

Differential antitumor immunity mediated by NKT cell subsets in vivo

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

CD1d-restricted T-cell subsets and dendritic cell function in autoimmunity

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

IL-21 induces the functional maturation of murine NK cells

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

Distinct functional lineages of human V(alpha)24 natural killer T cells

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

Release from regulatory T cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

Loss of IFN-gamma production by invariant NK T cells in advanced cancer.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4232058

Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells

18 August 2018

1 reference

12 December 2020

Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients

1 reference

12 December 2020

Limited correlation between human thymus and blood NKT?cell content revealed by an ontogeny study of paired tissue samples

1 reference

12 December 2020

IL-21 Counteracts the Regulatory T Cell-Mediated Suppression of Human CD4+ T Lymphocytes

1 reference

12 December 2020

Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma

1 reference

12 December 2020

T helper cell differentiation: IL-21 and T helper cell differentiation: Jack of all trades?

1 reference

12 December 2020

Identifiers

DOI

10.1038/CTI.2013.7

1 reference

7 October 2017

1 reference

7 October 2017

PubMed publication ID

25505948

1 reference